+ Watch VEEV
on My Watchlist
I like the technicals at this level. The vision of the company is strong, and they are innovating outside of the Salesforce platform, but I am buying solely on technicals. The stock bounced up from what looks like rock bottom at $17.11 I have been buying since that level and believe $22 is the next resistance level. After than I am a holder with a stop-loss at $21, which eyes on $26.
This outfit, public less than 200 days, will need the funds to be provided by a scheduled SPO to remain financially viable. I doubt it will bottom above $10.
Cloud services is the way of the future, buy this stock on the pull back.
- Life sciences is an industry that requires lots of regulated documentation. This is the perfect opportunity for a cloud-based SaaS company like Veeva.- CEO and co-founder is Peter Gassner, who was previously senior vice president of Salesforce.com. Gassner was directly responsible for building the salesforce platform. He knows what he's doing and has a proven track record.- IPO was in October and this company is still under-the-radar. Putting in the thumbs up before Wall Street catches on.- The company has already attracted big clients. They already have 33 of the 50 largest pharmaceutical companies as customers. They have grown their customer list at 59%/yr for the past two years.Will keep an eye on: 1) # of new users, 2) acquisition costs per new user, and 3) average revenue per user (ARPU).There's lots of growth ahead for Veeva. Outperform.
very interesting business model,it is profitable and growing at high rate .
Only viable cloud for pharmaceutical and biotech industries.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions